Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tumour Immune "Hotness" and Ki-67 Scoring Methods as Prognostic Biomarkers in Diffuse Large B-cell Lymphoma and Aggressive B-cell Lymphomas: An Immunohistochemical Study

NCT07804173 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT07804173
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07804173 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tumour Immune "Hotness" and Ki-67 Scoring Methods as Prognostic Biomarkers in Diffuse Large B-cell Lymphoma and Aggressive B-cell Lymphomas: An Immunohistochemical Study
Lead sponsor
Sohag University
Phase
Observational
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
February 1, 2027
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b-cell lymphoma and aggressive b-cell lymphomas